Search

Your search keyword '"Facial Pain metabolism"' showing total 204 results

Search Constraints

Start Over You searched for: Descriptor "Facial Pain metabolism" Remove constraint Descriptor: "Facial Pain metabolism"
204 results on '"Facial Pain metabolism"'

Search Results

1. Up-regulation of IL-1β and sPLA2-III in the medial prefrontal cortex contributes to orofacial and somatic hyperalgesia induced by malocclusion via glial-neuron crosstalk.

2. MicroRNA-6954-3p Downregulation Contributes to Orofacial Neuropathic Pain in Mice Via Targeting Voltage-Gated Sodium Channel β2 Subunit Protein.

3. Blockade of Piezo2 Pathway Attenuates Inflammatory and Neuropathic Pain in the Orofacial Area.

4. Cytoarchitecture and intercellular interactions in the trigeminal ganglion: Associations with neuropathic pain in the orofacial region.

5. The crucial role of NR2A mediating the activation of satellite glial cells in the trigeminal ganglion contributes to orofacial inflammatory pain during TMJ inflammation.

6. Contribution of inwardly rectifying potassium channel 4.1 in orofacial neuropathic pain: Regulation of pannexin 3 via the reactive oxygen species-activated P38 MAPK signal pathway.

7. Oxidative stress plays an important role in the central regulatory mechanism of orofacial hyperalgesia under low estrogen conditions.

8. RNA sequencing of the thalamus and rostral ventral medulla in rats with chronic orofacial pain.

9. Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors.

10. Quercetin, Main Active Ingredient of Moutan Cortex, Alleviates Chronic Orofacial Pain via Block of Voltage-Gated Sodium Channel.

11. Pain and salivary biomarkers of stress in temperomandibular disorders were affected by maxillary splints.

12. TET1 Participates in Complete Freund's Adjuvant-induced Trigeminal Inflammatory Pain by Regulating Kv7.2 in a Mouse Model.

13. The role of voltage-gated calcium channel α2δ-1 in the occurrence and development in myofascial orofacial pain.

14. The purinergic receptor P2X3 promotes facial pain by activating neurons and cytokines in the trigeminal ganglion.

15. In vivo imaging of cathepsin B in activated glia in the brain after orofacial formalin test.

16. Transplantation of olfactory ensheathing cells can alleviate neuroinflammatory responses in rats with trigeminal neuralgia.

17. Photic sensitization is mediated by cortico-accumbens pathway in rats with trigeminal neuropathic pain.

18. Emerging role of microglia and astrocyte in the affective-motivational response induced by a rat model of persistent orofacial pain.

19. Oral biosciences: The annual review 2022.

20. Astrocytic and microglial interleukin-1β mediates complement C1q-triggered orofacial mechanical allodynia.

21. Involvement of interferon gamma signaling in spinal trigeminal caudal subnucleus astrocyte in orofacial neuropathic pain in rats with infraorbital nerve injury.

22. Age-related Changes in Trigeminal Ganglion Macrophages Enhance Orofacial Ectopic Pain After Inferior Alveolar Nerve Injury.

23. Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia.

24. Parkia platycephala Lectin (PPL) Inhibits Orofacial Nociception Responses via TRPV1 Modulation.

25. Differential roles of NMDAR subunits 2A and 2B in mediating peripheral and central sensitization contributing to orofacial neuropathic pain.

26. NGF-Induced Upregulation of CGRP in Orofacial Pain Induced by Tooth Movement Is Dependent on Atp6v0a1 and Vesicle Release.

27. P2Y 14 receptor in trigeminal ganglion contributes to neuropathic pain in mice.

28. Development of a Nanoformulation for Oral Protein Administration: Characterization and Preclinical Orofacial Antinociceptive Effect.

29. 5-HT3/7 and GABA B receptors mediate inhibition of trigeminal nociception by dietary supplementation of grape seed extract.

30. Loss of Elp1 disrupts trigeminal ganglion neurodevelopment in a model of familial dysautonomia.

31. Chronic facial inflammatory pain-induced anxiety is associated with bilateral deactivation of the rostral anterior cingulate cortex.

32. Prolactin signaling modulates stress-induced behavioral responses in a preclinical mouse model of migraine.

33. Mechanism of Catechol-O-methyltransferase Regulating Orofacial Pain Induced by Tooth Movement.

34. The α2δ-1-NMDAR1 interaction in the trigeminal ganglion contributes to orofacial ectopic pain following inferior alveolar nerve injury.

35. Transient Receptor Potential (TRP) Ion Channels in Orofacial Pain.

36. Glia and Orofacial Pain: Progress and Future Directions.

37. N/OFQ modulates orofacial pain induced by tooth movement through CGRP-dependent pathways.

38. Connexin 36 Mediates Orofacial Pain Hypersensitivity Through GluK2 and TRPA1.

39. Effects of trigeminal nerve injury on the expression of galanin and its receptors in the rat trigeminal ganglion.

40. The role of connexins and pannexins in orofacial pain.

41. LOW-DOSE NALTREXONE REVERSES FACIAL MECHANICAL ALLODYNIA IN A RAT MODEL OF TRIGEMINAL NEURALGIA.

42. Reduced activity of GAD67 expressing cells in the reticular thalamus enhance thalamic excitatory activity and varicella zoster virus associated pain.

43. Microglia-Astrocyte Communication via C1q Contributes to Orofacial Neuropathic Pain Associated with Infraorbital Nerve Injury.

44. The fifth cranial nerve in headaches.

45. Cytokines, Masticatory Muscle Inflammation, and Pain: an Update.

46. Hemokinin-1 Gene Expression Is Upregulated in Trigeminal Ganglia in an Inflammatory Orofacial Pain Model: Potential Role in Peripheral Sensitization.

47. Neurotransmitter and tryptophan metabolite concentration changes in the complete Freund's adjuvant model of orofacial pain.

48. Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain.

49. The opposing contribution of neurotrophin-3 and nerve growth factor to orofacial heat hyperalgesia in rats.

50. Peripheral glutamate receptor and transient receptor potential channel mechanisms of craniofacial muscle pain.

Catalog

Books, media, physical & digital resources